Bourgeon Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3
| Closed | -$134 | – | 338 |
|
|
2022
Q4 | $134 | Hold |
3
| – | – | ﹤0.01% | 362 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 381 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 289 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 287 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 267 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 277 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 277 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 278 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 274 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 300 |
|
|
2020
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 258 |
|